Actinium Pharmaceuticals Announces Three ASH 2026 Abstracts Highlighting Iomab-ACT Clinical Results in CAR T-Cell Therapy and Sickle Cell Disease
The Quick Take
The three abstracts strengthen the clinical foundation for Iomab-ACT's development as a targeted conditioning platform for cellular and gene therapies across cancer and nonmalignant diseases Phase 1b/2 trial evaluates targeted immune conditioning with Iomab-ACT before standard commercial...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
American Liver Foundation Honors Sanford Burnham Prebys Dr. Michael Karin with 2026 Distinguished Scientific Achievement Award
Award recognizes Karin's nearly five decades of groundbreaking discoveries in understanding liver biology and inflammation FAIRFIELD, N.J., Nov. 4, 2026…
Business
/C O R R E C T I O N - The Michael J. Fox Foundation for Parkinson's Research/
In the news release, Michael J. Fox Foundation and Medtronic Partner to Help More People with Parkinson's Understand Deep Brain Stimulation, issued Nov. 4,…
Business
Artificial Intelligence in Energy Market worth $96.99 billion by 2032 - Report by MarketsandMarkets™
DELRAY BEACH, Fla., Nov. 4, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the AI in Energy Market is projected to grow from USD 17.62 billion in 2026…
Business
Nucleus Research Releases 2026 IIoT Data Platform Technology Value Matrix
Leaders in the IIoT data platform market include AVEVA, Cumulocity, Inductive Automation, Litmus, Siemens, and Velotic. MIAMI, Nov. 4, 2026 /PRNewswire/ --…